# : Pulpal Blood Flow With the Use of Intra-nasal Anesthetic

> **NCT03368391** · PHASE4 · UNKNOWN · sponsor: **Louisiana State University Health Sciences Center in New Orleans** · enrollment: 25 (estimated)

## Conditions studied

- Local Anesthetic Drug Adverse Reaction
- Local Infiltration
- Pulp Disease, Dental

## Interventions

- **DRUG:** tetracaine HCl and oxymetazoline HCL
- **DRUG:** 2% Lidocaine with 1:100,000 epinephrine
- **DRUG:** 3% Mepivacaine with 1:100,000 epinephrine
- **DRUG:** saline intranasal
- **DRUG:** saline infiltration

## Key facts

- **NCT ID:** NCT03368391
- **Lead sponsor:** Louisiana State University Health Sciences Center in New Orleans
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-03
- **Primary completion:** 2018-06-30
- **Final completion:** 2018-06-30
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2017-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03368391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03368391, ": Pulpal Blood Flow With the Use of Intra-nasal Anesthetic". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03368391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*